市場調査レポート
商品コード
1073841
敗血症診断の世界市場(2022年~2028年):製品別、技術別、地域別の市場規模調査と予測Global Sepsis Diagnostics Market Size study, by Product, by Technology and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
敗血症診断の世界市場(2022年~2028年):製品別、技術別、地域別の市場規模調査と予測 |
出版日: 2022年04月30日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界の敗血症診断の市場規模は、2021年に約4億6,147万米ドルとなり、2022年~2028年の予測期間中に9.00%以上の健全な成長率で成長すると予想されています。市場を牽引する主な要因には、院内感染の増加や敗血症の高い発生率、新興国での迅速な診断の発展と成長機会などがあります。しかし、熟練した専門家の不足と自動診断装置の高コストが、予測期間における市場の成長を阻害しています。
当レポートでは世界の敗血症診断市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。
List of figures
Global Sepsis Diagnostics Market is valued at approximately USD 461.47 million in 2021 and is anticipated to grow with a healthy growth rate of more than 9.00% over the forecast period 2022-2028. Sepsis can be defined as the body's reaction to infection as bacterial, viral, fungal, parasitic which may lead to a systemic inflammatory reaction and eventually organ dysfunction and/or failure. The rising incidence of hospital-acquired infections and high incidence of sepsis has led to the adoption of Sepsis Diagnostics across the forecast period. For Instance: as per the CDC incidence of sepsis among hospitalized patients is rising by 8.7% per year. It is estimated that there are more than 1,000,000 incidences of sepsis among hospitalized patients annually in the nation {Source: CDC, 2018). With the rapid increase in HAIs worldwide. Also, with the development of rapid diagnostic and growth opportunities in emerging economies, the adoption & demand for Sepsis Diagnostics is likely to increase the market growth during the forecast period. However, lack of skilled professionals and high cost of automated diagnostic devices impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Sepsis Diagnostics market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the presence of a highly developed healthcare system, high adoption of innovative sepsis diagnostic technologies. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. Factors such as rising number of surgical procedures, increasing incidence of healthcare-associated infections would create lucrative growth prospects for the Sepsis Diagnostics market across Asia-Pacific region.
Major market players included in this report are:
Axis-Shield Diagnostics (UK)
Becton, Dickinson and Company (US)
Danaher Corporation (US)
Thermo Fisher Scientific (US)
Bruker Corporation (US)
Abbott Laboratories (US)
Axis-Shield Diagnostics (UK)
Quidel Corporation (US)
EKF Diagnostics (UK)
Seegene Inc. (South Korea)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Blood Culture Media
Assays & Reagents
Instruments
Software
By Technology:
Blood Culture
Immunoassays
Molecular Diagnostics
Flow Cytometry
Microfluidics
Biomarkers
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Sepsis Diagnostics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors